Endpoints News 6. Jan. 2026 Arrowhead’s RNAi obesity programs head to Phase 2 after encouraging early data
Endpoints News 5. Jan. 2026 FDA raises new questions with Sanofi's MS drug in release of rejection letter
Endpoints News 5. Jan. 2026 HHS urges Supreme Court to decline AstraZeneca's petition over Medicare price negotiations
Endpoints News 5. Jan. 2026 US to stop recommending six vaccines for all kids, prioritizing individual choice and higher-risk groups
Endpoints News 5. Jan. 2026 Crinetics reports robust full-quarter sales for rare disease drug Palsonify
Endpoints News 5. Jan. 2026 Aktis Oncology eyes $181M listing to start industry’s anticipated IPO rebound
Endpoints News 5. Jan. 2026 Novo Nordisk launches Wegovy pill at $25 per month for insured patients, $149 cash
Endpoints News 31. Dez. 2025 AbbVie does T cell engager deal in China for Zelgen's DLL3-targeted drug